Boothbay Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-19,213
| Closed | -$6.27M | – | 1853 |
|
|
2025
Q2 | $6.27M | Buy |
19,213
+9,123
| +90% | +$2.52M | 0.19% | 241 |
|
|
2025
Q1 | $2.72M | Buy |
+10,090
| New | +$2.59M | 0.09% | 359 |
|
|
2024
Q4 | – | Sell |
-2,556
| Closed | -$703K | – | 1469 |
|
|
2024
Q3 | $703K | Sell |
2,556
-830
| -25% | -$216K | 0.02% | 864 |
|
|
2024
Q2 | $823K | Sell |
3,386
-11,630
| -77% | -$1.84M | 0.02% | 790 |
|
|
2024
Q1 | $2.24M | Buy |
+15,016
| New | +$2.5M | 0.06% | 469 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1635 |
|
|
2022
Q4 | – | Sell |
-1,093
| Closed | -$219K | – | 1977 |
|
|
2022
Q3 | $219K | Sell |
1,093
-6,791
| -86% | -$1.3M | 0.01% | 1761 |
|
|
2022
Q2 | $1.15M | Buy |
+7,884
| New | +$1.12M | 0.04% | 752 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2259 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1835 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1881 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1831 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1513 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1224 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1029 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 951 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 838 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 839 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 758 |
|
|
2019
Q2 | – | Sell |
-12,800
| Closed | -$982K | – | 723 |
|
|
2019
Q1 | $1.2M | Buy |
+12,800
| New | +$1.07M | 0.16% | 199 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 650 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 780 |
|
|
2018
Q2 | – | Sell |
-2,666
| Closed | -$264K | – | 736 |
|
|
2018
Q1 | $318K | Sell |
2,666
-666
| -20% | -$85.9K | 0.05% | 453 |
|
|
2017
Q4 | $423K | Buy |
+3,332
| New | +$419K | 0.08% | 316 |
|
|
2017
Q3 | – | Sell |
-4,186
| Closed | -$357K | – | 596 |
|
|
2017
Q2 | $334K | Buy |
+4,186
| New | +$268K | 0.09% | 369 |
|